CIAM
RCKT icon

Caitong International Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Caitong International Asset Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14K Sell
4,097
-13,276
-76% -$44.1K ﹤0.01% 1072
2026
Q1 		$62.2K Buy
17,373
+11,551
+198% +$45.9K 0.01% 715
2025
Q4 		$20.4K Buy
+5,822
New +$19.9K 0.01% 980
2025
Q2 		– Sell
-218
Closed -$1.45K – 2393
2025
Q1 		$1.45K Sell
218
-5,740
-96% -$56.7K ﹤0.01% 1458
2024
Q4 		$74.9K Buy
+5,958
New +$89.7K 0.07% 318

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Caitong International Asset Management's RCKT Position: Q2 2026 in Review

Caitong International Asset Management reduced its Rocket Pharmaceuticals (RCKT) stake by 76% in Q2 2026, selling an estimated $44.1K and leaving 4,097 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #1072.

Caitong International Asset Management first reported a position in RCKT in Q4 2024 and has held it in 5 quarters since. The position peaked at $74.9K in Q4 2024. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Caitong International Asset Management held 4,097 shares of Rocket Pharmaceuticals worth $14K as of Q2 2026.
  • Caitong International Asset Management sold 13,276 Rocket Pharmaceuticals shares in Q2 2026, an estimated $44.1K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1072 holding.
  • Caitong International Asset Management first reported a position in Rocket Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • Caitong International Asset Management's Rocket Pharmaceuticals position peaked at $74.9K in Q4 2024.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.